These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2793373)

  • 1. Phase I study of vincristine and escalating doses of etoposide.
    Jackson DV; Cruz JM; Zekan PJ; Caponera ME; Spurr CL; White DR; Richards F; Muss HB
    Invest New Drugs; 1989 Jul; 7(2-3):203-7. PubMed ID: 2793373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination high-dose etoposide and vincristine infusion.
    Jackson DV; Cruz JM; White DR; Muss HB; Chauvenet AR
    Invest New Drugs; 1990; 8 Suppl 1():S59-64. PubMed ID: 2380018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
    Krigel RL; Palackdharry CS; Padavic K; Haas N; Kilpatrick D; Langer C; Comis R
    J Clin Oncol; 1994 Jun; 12(6):1251-8. PubMed ID: 8201386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer.
    Fukuoka M; Masuda N; Negoro S; Takada M; Kudoh S; Kusunoki Y; Matsui K; Takifuji N; Tachikawa A; Kawahara M
    Cancer; 1991 Jul; 68(2):284-8. PubMed ID: 2070326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
    Santana VM; Schell MJ; Williams R; Bowman LC; Thompson EI; Brenner MK; Mirro J
    Bone Marrow Transplant; 1992 Nov; 10(5):457-62. PubMed ID: 1464010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study with combination therapy of pirarubicin, etoposide, and vincristine in small-cell lung cancer.
    Patzer DC; Koschel G; Greifenberg B; Kaukel E
    Am J Clin Oncol; 1990; 13 Suppl 1():S24-8. PubMed ID: 1963273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-escalation study of oral etoposide and carboplatin in patients with advanced lung cancer.
    Atagi S; Furuse K; Kawahara M; Kodama N; Ogawara M; Kubota K; Matsui K; Kusunoki Y; Masuda N; Takada M; Negoro S; Fukuoka M
    Jpn J Clin Oncol; 1996 Oct; 26(5):316-21. PubMed ID: 8895671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors.
    McNall-Knapp RY; Williams CN; Reeves EN; Heideman RL; Meyer WH
    Pediatr Blood Cancer; 2010 Jul; 54(7):909-15. PubMed ID: 20405511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial.
    Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer.
    Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K
    Cancer Chemother Pharmacol; 1990; 25(5):367-70. PubMed ID: 2155064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
    Moore DF; Swan F; Yau J; Rodriguez MA; McLaughlin P; Sarris A; Romaguera J; Younes A; Hagemeister FB; Cabanillas F
    Clin Oncol (R Coll Radiol); 1995; 7(5):300-3. PubMed ID: 8580055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856.
    Lester EP; Petroni GR; Barcos M; Johnson JL; Millard FE; Cooper MR; Omura GA; Frei E; Peterson BA
    Cancer Invest; 2001; 19(5):447-58. PubMed ID: 11458812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association.
    Thomas GW; Muss HB; Jackson DV; McCulloch J; Ramseur W; McFarland J; Hoen H; Pavy M; Heath R
    Cancer Chemother Pharmacol; 1994; 35(2):165-8. PubMed ID: 7987995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of a carboplatin-etoposide combination in advanced thoracic cancer.
    Tueni E; Sculier JP; Klastersky J
    Eur J Cancer Clin Oncol; 1988 Jun; 24(6):963-7. PubMed ID: 3044803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
    J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
    Tweddle DA; Pinkerton CR; Lewis IJ; Ellershaw C; Cole M; Pearson AD
    Med Pediatr Oncol; 2001 Jan; 36(1):239-42. PubMed ID: 11464894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
    Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
    Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.